NPFFR2
Basic information
Region (hg38): 4:72031902-72148305
Previous symbols: [ "GPR74" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NPFFR2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 17 | 20 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 4 | |||||
Total | 0 | 0 | 19 | 2 | 3 |
Variants in NPFFR2
This is a list of pathogenic ClinVar variants found in the NPFFR2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-72031921-C-T | not specified | Likely benign (Aug 13, 2021) | ||
4-72032006-C-G | Benign (Feb 25, 2018) | |||
4-72032098-A-C | not specified | Uncertain significance (Jul 14, 2021) | ||
4-72032131-A-T | not specified | Uncertain significance (Oct 22, 2021) | ||
4-72128604-T-C | not specified | Uncertain significance (Oct 27, 2022) | ||
4-72128735-C-G | not specified | Uncertain significance (Mar 14, 2023) | ||
4-72128769-A-G | not specified | Uncertain significance (Sep 01, 2021) | ||
4-72128775-G-A | not specified | Uncertain significance (Jan 03, 2024) | ||
4-72128806-G-A | not specified | Uncertain significance (Mar 29, 2024) | ||
4-72128808-A-G | Benign (Jan 08, 2018) | |||
4-72128859-A-C | not specified | Uncertain significance (Mar 16, 2024) | ||
4-72128916-G-A | not specified | Uncertain significance (Dec 05, 2022) | ||
4-72138063-T-C | not specified | Uncertain significance (Jun 21, 2023) | ||
4-72138099-G-A | Likely benign (Nov 20, 2018) | |||
4-72146992-T-C | Benign (Dec 31, 2019) | |||
4-72146994-T-C | not specified | Uncertain significance (Aug 02, 2022) | ||
4-72147028-C-G | not specified | Uncertain significance (Nov 10, 2021) | ||
4-72147100-T-G | not specified | Uncertain significance (Jan 02, 2024) | ||
4-72147262-T-C | not specified | Uncertain significance (Oct 05, 2022) | ||
4-72147355-A-G | not specified | Uncertain significance (Nov 13, 2023) | ||
4-72147462-A-G | not specified | Uncertain significance (Jun 26, 2023) | ||
4-72147477-A-T | not specified | Uncertain significance (Feb 28, 2024) | ||
4-72147649-C-T | not specified | Uncertain significance (Sep 22, 2021) | ||
4-72147724-C-A | not specified | Likely benign (May 14, 2024) | ||
4-72147741-A-C | not specified | Uncertain significance (Dec 23, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NPFFR2 | protein_coding | protein_coding | ENST00000308744 | 4 | 116264 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.67e-7 | 0.653 | 125515 | 1 | 232 | 125748 | 0.000927 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.17 | 336 | 281 | 1.20 | 0.0000136 | 3461 |
Missense in Polyphen | 101 | 89.161 | 1.1328 | 1200 | ||
Synonymous | -1.62 | 126 | 105 | 1.20 | 0.00000533 | 992 |
Loss of Function | 1.15 | 13 | 18.3 | 0.711 | 8.70e-7 | 199 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00121 | 0.00121 |
Ashkenazi Jewish | 0.00239 | 0.00228 |
East Asian | 0.000707 | 0.000707 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000964 | 0.000959 |
Middle Eastern | 0.000707 | 0.000707 |
South Asian | 0.00100 | 0.000980 |
Other | 0.00263 | 0.00261 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for NPAF (A-18-F-amide) and NPFF (F-8-F-amide) neuropeptides, also known as morphine-modulating peptides. Can also be activated by a variety of naturally occurring or synthetic FMRF-amide like ligands. This receptor mediates its action by association with G proteins that activate a phosphatidylinositol- calcium second messenger system.;
- Pathway
- Neuroactive ligand-receptor interaction - Homo sapiens (human);GPCRs, Class A Rhodopsin-like;Signaling by GPCR;Signal Transduction;Orexin and neuropeptides FF and QRFP bind to their respective receptors;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;G alpha (q) signalling events;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.0777
Intolerance Scores
- loftool
- 0.932
- rvis_EVS
- 0.36
- rvis_percentile_EVS
- 74.63
Haploinsufficiency Scores
- pHI
- 0.0549
- hipred
- N
- hipred_score
- 0.144
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0771
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Npffr2
- Phenotype
- cellular phenotype; hematopoietic system phenotype; immune system phenotype;
Gene ontology
- Biological process
- G protein-coupled receptor signaling pathway;neuropeptide signaling pathway;detection of abiotic stimulus;cellular response to hormone stimulus;regulation of MAPK cascade;regulation of adenylate cyclase activity;regulation of cAMP-dependent protein kinase activity
- Cellular component
- plasma membrane;integral component of plasma membrane;actin cytoskeleton
- Molecular function
- G protein-coupled receptor activity;neuropeptide receptor activity;opioid receptor binding